Singapore markets open in 8 hours 27 minutes

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
248.16-9.14 (-3.55%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close257.30
Open257.30
Bid249.00 x 1100
Ask249.30 x 1100
Day's range246.33 - 257.30
52-week range76.59 - 331.68
Volume3,007,117
Avg. volume4,766,814
Market cap18.484B
Beta (5Y monthly)1.62
PE ratio (TTM)N/A
EPS (TTM)-13.84
Earnings date08 Nov 2021 - 12 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est264.20
  • Motley Fool

    Is Novavax Delaying Its COVID Vaccine EUA Filings Yet Again?

    Novavax (NASDAQ: NVAX) has found hitting target dates for regulatory filings is easier said than done. The company delayed its planned submissions for Emergency Use Authorization for COVID-19 vaccine NVX-CoV2373 earlier this year. In this Motley Fool Live video recorded on Sept. 15, Motley Fool contributors Keith Speights and Brian Orelli talk about whether Novavax could experience further delays and what it might mean for the stock.

  • Yahoo Finance Video

    ‘I don’t think we’ve done enough to get vaccines overseas’: Doctor

    Dr. Arthur Caplan, NYU Langone Health, Division of Medical Ethics at NYU School of Medicine, joins Yahoo Finance to discuss the latest on the coronavirus vaccines and booster shots.

  • Zacks

    Novavax (NVAX) Applies to WHO for COVID-19 Vaccine Listing

    On being granted the emergency use listing for Novavax's (NVAX) COVID-19 vaccine by WHO, it is to become eligible to supply the same to numerous countries participating through the COVAX facility